Summary Recently, we demonstrated that approximately 60 % of GLUT 1 in a crude membrane fraction of rat skeletal muscle originates from perineurial sheaths. To study the in vivo regulation of GLUT 1 expression in different tissues in muscles, we measured the level of GLUT 1 in crude muscle membranes and in perineurial sheaths in diabetic (fa/fa) Zucker rats and lean controls, with and without metformin treatment. The GLUT 1 concentration in perineurial sheaths was identical in all four groups of rats, both when measured by quantitative immunofluorescence and by immunoblotting and densitometry. In a fraction of crude membranes of soleus muscles GLUT 1 expression was more than two-fold higher in (fa/fa) rats than in lean controls (p < 0.005). Metformin treatment significantly elevated GLUT 1 in control rats (p < 0.05) and tended to decrease GLUT 1 in diabetic rats (p < 0.075). The expressions of GLUT 1 and GLUT 4 in crude muscle membranes were inversely correlated (t7 < 0.01), and GLUT 1 expression correlated positively with fasting glucose (p < 0.05). In conclusion, GLUT 1 expression in perineurial sheaths is unaffected by alterations in glucose homeostasis and by the genes responsible for obesity and diabetes in the Zucker rat. GLUT 1 expression in a crude membrane fraction of soleus muscle is increased in the diabetic animals, likely due to an increased expression in muscle cells proper. [Diabetologia (1994) 37: 443--448] 
in adipocytes, it has been suggested that GLUT 1 is of particular importance for the basal glucose uptake in skeletal muscle cells. However, in other studies using immunocytochemical techniques labelling for GLUT 1 on sections of skeletal muscle was confined to the blood-brain/nerve-barrier tissues, i.e. perineurial sheaths and endoneurial vessels [10] [11] [12] , and it has been proposed that the function of GLUT 1 in skeletal muscle is to mediate an adequate supply of glucose to the nerve fibres.
We have recently reported that GLUT 1 from perineurial sheaths accounts for approximately 60 % of the GLUT 1 content in a crude membrane fraction from rat skeletal muscles, and that the remaining GLUT 1 is likely to represent the "constitutive" glucose transporter in the muscle cells proper [6] . In this light, interpretation and evaluation of the significance of previous resuits concerning GLUT 1 expression in membrane fractions of skeletal muscle in a variety of adaptive and pathological states is complicated by the lack of knowledge of the site of change.
Skeletal muscle of the genetically obese Zucker rat (fa/fa) is insulin resistant [13, 14] , and a decreased glucose transport, both in the basal and the insulin stimulated state has been demonstrated [14] . Some studies have been published concerning the expression of glucose transporters in skeletal muscle from this animal model [15] [16] [17] [18] [19] [20] . However, none of these studies have specifically dealt with GLUT 1.
To acquire information about the regulation of GLUT 1 expression in perineurial sheaths and muscle membranes, we have studied the level of GLUT 1 in muscle membrane and perineurial sheath in obese Zucker rats and their lean littermates, before and after amelioration of the hyperinsulinaemia and hyperglycaemia by treatment with the oral antidiabetic drug, metformin.
Materials and methods

Treatment of animals.
Obese male Zucker rats (fa/fa) and their lean littermates (Fa/-) were purchased from Charles River Laboratories (Cambridge, Mass., USA) at 8 weeks of age. Seven obese Zucker rats and seven lean controls were randomly chosen to be treated with metformin, and the remaining seven rats from each group served as controls. By use of a gastric tube, the rats assigned for treatment were given mefformin (N,N-dimethylbiguanid) dissolved in 0.9 % NaCI every morning initially at a dose of 90 mg/day for 6 days increasing to 180 mg/day for 6 days, 225 mg/day for 6 days and finally 270 mg/day for 6 days while the controls were given vehicle only. The last dose of metformin or vehicle was given 24 h before the day of study. The animals were weighed twice weekly. The diabetic Zucker rats were significantly more obese than their lean littermates at the onset of metformin treatment (body weight 367 + 16 vs 277 + 6.5 g). Weight gain during the study was unaffected by metformin treatment in both groups [21] .
After an overnight fast, the animals were anaesthetized by i. p. injection of mebumal and weighed. The soleus muscles were excised and immediately frozen by immersion in n-hexane at -70"C and stored at the same temperature until analysis. Femoral nerves were excised, dissected free of loose connective tissue, and frozen.
Analysis o[ blood samples.
A commercially available RIA kit was used for determination of insulin as described by the manufacturer (Novo-Nordisk, Bagsvaerd, Denmark) using rat insulin as standard, and glucose was measured by an automated glucose analyser (YSI 23AM; Yellow Springs Instruments, Yellow Springs, Ohio, USA). Glycated fructosamine was analysed using a commercially available kit (Precimat; Boehringer Mannheim, Meylan, France), and data were normalized to concentration of plasma protein.
Immunobloning. Frozen soleus muscles were homogenized for 7 s using a Polytron (max. setting) in 3 ml of 50 mmol/l Hepes, pH 7.6, 250 mmol/l sucrose, 10 retool/1 EDTA, 1.5 retool/1 phenylmethylsulphonyl-flouride (PMSF) and 400 KIU/ml Trasylol. A crude membrane fraction was isolated from the homogenate by a centrifugation procedure, essentially as described in [7] with the modifications described in [22] . Protein content was deter-A. Handberg et al.: GLUT 1 in rat muscle membranes mined by the method of Bradford using the kit from Biorad (Richmond, Calif., USA), and protease inhibitors were added to the remains of the crude membrane preparation (1.5 mmol/1 PMSF and 400 KIU/ml Trasylol). Samples containing 50 ktg of protein from each crude membrane preparation were analysed in duplicate by SDS-PAGE and Western Blotting as described [22] . Protein recovery in the crude membrane preparations was identical in the four groups (data not shown).
Femoral nerves (3.9--6.8 mg) were homogenized in 0.4 ml of homogenization buffer with protease inhibitors (1.5 mmol/1 PMSF and 400 KIU/ml Trasylol) and samples of 50 gl of the homogenates were analysed by SDS-PAGE and Western Blotting as described above.
Protein G-purified monoclonal antibody raised against GLUT 1 purified from human erythrocyte membranes and reacting with a peptide corresponding to the 15 C-terminal amino acids was used for detection of GLUT 1 [23] . Quantitation of immunoreactivity was performed by densitometric scanning using a preparation of adipocyte plasma membrane as internal standard.
Fluorescence labelling of GLUT 1 in tissue sections. Soleus muscles were divided into three tissue blocks by two transverse cuts at random positions on the long axis of the muscle. From each tissue block, six cryosections were cut 6 ~tm thick and all sections from one soleus muscle were adsorbed on the same gelatin coated slide. Slides were incubated with Tris-buffered saline (10 mmol/1Tris-HC1, pH 7.4 and 0.9 % NaC1) containing 5 % bovine serum albumin for 30 rain at room temperature to block non-specific binding, essentially as previously described [6] . Triplicate sections from each tissue block (in total nine sections on each slide) were incubated for 1 h with monoclonal GLUT 1 antibody (see above), diluted 1:100 in Tris-buffered saline with 1% bovine serum albumin. Duplicate sections from each tissue block (in total six sections on each slide) were incubated with dilution buffer alone and served as background sections. The cryosections were washed and incubated with BODIPY conjugated goat anti-mouse IgG antibody (B2752; Molecular Probes, Eugene, Ore., USA) for 1 h. Finally, the sections were rinsed in Tris-buffered saline, mounted in Aquamount (BDH, Dorset, UK) and kept in the dark at-20~ until image analysis.
Quantitation of immunofluorescence labelling in tissue sections
Instrumentation. The fluorescence intensity emitted from the specifically bound secondary antibody was measured using a Zeiss Axiovert 10 epifluorescense microscope equipped with a Plan Neofluar water immersion objective (Magnification x 16, numerical aperture 0.50), a XBO 75 W light source, a fast-shutter and a Dage/MTI SIT 66 camera (Michigan City, Ind.,USA) connetted to a MVP-AT version 10 digitizer (Matrox Electronic Systems Limited, DORVAL, Quebec, Canada). The following set of filters was used: excitation 485/20 nm, beamsplitter 510 nm and emission 515-565 nm (Zeiss, Oberkochen, Germany). The system was operated by the software package IMAGE1/AT 4.01 b, (Universal Imaging Corporation, West Chester, Pa., USA).
Quantitation of fluorescence. After adjustment of black level, high voltage (550 keV) and gain (2.04) were adjusted such that the main part of the intensities (grey values) were within the midrange of the camera sensitivity. From each slide, in the 3 x 3 specifically labelled and in one background section, an area was randomly selected and an image was acquired by averaging and digitizing 16 video frames (PAL; 25 frames/s). The total illumination time was 1.5 s. The resulting image (512 x 512 pixels) was stored on a hard disk. After acquisition of the images, one dark and one white reference image were obtained using an uranyl-glass and ap < 0.002, bp < 0.01 vs untreated fa/fa rats; ep < 0.01, dp < 0.005 vs metformin-treated fa/fa rats (one-sided Mann-Whitney).
Values are given as mean + SEM images were corrected for background and shading [24] . The immunofluorescence was quantitated by collecting grey values higher than 60 as this signal represents immunoreactivity corresponding to the perineurial sheaths ( Fig. 1) . In each image the intensity in the undistorted part of the image area (3/4) was integrated. The sum of the integrated intensities from nine images were taken to represent a muscle.
Peroxidase-anti-peroxidase labelling. The localization of GLUT 1 in multiple sections from 4-10 different levels of the excised femoral nerve was visualized by the peroxidase-anti-peroxidase method, essentially as described in [6] .
Morphometric analysis. Mean area fractions of perineurial sheaths in the BODIPY labeled sections of soleus muscle from each animal were determined as the area with grey value greater than 60 divided by the total image area. Mean area fractions of GLUT 1 immunoreactivity in peroxidase-anti-peroxidase labelled cross-sections of excised femoral nerves were determined by an analogous procedure and expressed as area of perineurial and endoneurial sheath divided by the total area of the nerve section. 
Statistical analysis
Data in text, tables and figures are given as mean + SEM. Statistical significance between groups was tested by use of a MannWhitney test for unpaired comparisons, and Spearmans rho for correlation was used. One or two-sided tests were used where appropiate (indicated in Table 1 ). Statistical analysis was performed using MEDSTAT version 2.1, programmed by Drs. H. R. Wulff and P. Schlichting, Herlev University Hospital, Denmark.
Results
P e r t i n e n t v a l u e s u s e d for c h a r a c t e r i z a t i o n of g l u c o s e h o m e o s t a s i s of a n i m a l s a r e given in T a b l e 1. T h e d a t a p r e s e n t e d i n T a b l e 1 h a v e b e e n p r e v i o u s l y r e p o r t e d [21].
T h e c o n c e n t r a t i o n of G L U T 1 in p e r i n e u r i a l s h e a t h s of i n t r a m u s c u l a r n e r v e s a n d e x c i s e d f e m o r a l n e r v e s , respectively, was a s s e s s e d b y use o f t w o d i f f e r e n t m e t h o d s : Fig.2a,b . GLUT 1 immunoreactivity in perineurial sheaths of excised femoral nerves. Femoral nerves were excised and homogenates were subjected to SDS-PAGE and immunoblotting. GLUT 1 immunoreactivity was determined by densitometry and results were corrected for the weight of excised nerve and area fraction of perineurial sheath in the nerves, a) Immunoblot of nerve-homogenate in three two-fold dilutions. Arrow indicate 45 kDa molecular weight marker, b) GLUT 1 expression (arbitrary units) in control rats (Fa/-) and obese diabetic Zucker rats (fa/fa) without (solid bars) and with (hatched bars) treatment with metformin Fig.3a,b . GLUT 1 immunoreactivity of crude membranes from the soleus muscle. A crude membrane fraction was isolated from the soleus muscles and analysed by SDS-PAGE and immunoblotting, using GLUT 1 antibody as primary antibody, a) Representative immunoblots of crude membranes in duplicates from (from left to fight) untreated and metformin treated control rats and diabetic (fa/fa) Zucker rats, respectively. Arrow indicates 45 kDa molecular weight marker, b) Immunoreactivity was quantitated by densitometry and results were expressed relatively to protein concentration in the crude membranes. Solid bars, untreated rats and hatched bars, metformin-treated rats. * p < 0.025 and ** p < 0.0025 vs untreated control (Fa/-) rats quantitative immunofluorescence (Fig. 1 a,b) and immunoblotting of nerve homogenates (Fig. 2 a) . Using quantitative immunofluorescence, we found no difference in mean G L U T 1 perineurial concentration in muscles from (fa/fa) rats compared with controls (208.2+12.9 vs 203.3+11.4 arbitrary units, NS) (Fig. 1 c) . Furthermore, mean perineurial G L U T 1 concentration in both groups was unaffected by metformin treatment (Fig. 1 c) . The volume fraction of perineurial sheath in soleus muscle, determined morphometrically, was identical in the obese (fa/fa) Zucker rats without and with treatment with metformin and also when compared with the lean (Fa/-) controls without and with metformin treatment (0.0023 + 0.0007 % vs 0.0029 + 0.0006 % vs 0.0020 _+ 0.0004 % vs 0.0017 + 0.0006 %, respectively NS). When perineurial G L U T 1 concentration was determined in homogenates of excised femoral nerve by immunoblotting and densitometry, results were corrected group-wise for area fraction of perineurial sheaths in the dissected nerves, and expressed relative to the weight of nerve used for e ach preparation. G L U T 1 content in femoral nerves from the obese (fa/fa) rats was identical to the non-treated control (Fa/-) rats (0.158_+0.026 vs 0.188_+0.024 arbitrary units, NS). Metformin did not influence G L U T 1 expression in either the obese (fa/fa) (0.158_+ 0.026 vs 0.205 _ 0.020 arbitrary units, NS) or in the control (Fa/-) rats (0.187 _+ 0.024 vs 0.177 + 0.026 arbitrary units, NS) (Fig. 2b) . Area fractions of perineurial sheaths in the four groups of animals studied were not significantly different (0.110 + 0.011% vs 0.120 _ 0.012% vs 0.124 _ 0.023 % vs 0.129 _+ 0.022 %, repectively).
G L U T 1 expression in crude m e m b r a n e fractions of soleus muscles was quantitated by immunoblotting and densitometry (Fig. 3a) . In the untreated animals, G L U T 1 content was significantly higher in the fa/fa rats compared to the control group (5.43_+0.63 vs 2.50 _+ 0.23 arbitrary units, p < 0.005) (Fig. 3b) . Treatment with metformin significantly increased the G L U T 1 expression in the control (Fa/-) group (2.50_+ 0.23 vs 4.01 + 0.65 arbitrary units, p < 0.05) whereas in the obese (fa/fa) rats the G L U T 1 content tended to be decreased (5.43 _+ 0.63 vs 3.61 + 0.28 arbitrary units, p < 0.075) (Fig. 3b) . Fasting glucose was positively correlated with G L U T 1 expression in crude membranes isolated from soleus muscle (rho = 0.44, p < 0.05) whereas fasting insulin was not correlated with GLUT 1 expression in soleus muscle. GLUT 4 expression was previously measured in crude muscle membranes of the soleus muscle from the same animals [21] , and GLUT 1 and GLUT 4 expression was inversely correlated (rho = 0.52,p < 0.01).
Iliseur,~on
Among tissues present in rat skeletal muscle, GLUT 1 is expressed with the highest density in the perineurial sheaths and the endoneurial vessels of intramuscular nerves [6, [10] [11] [12] . Recently we demonstrated that the muscle membranes proper contribute less than one-half of the total amount of GLUT 1 recovered in a crude membrane fraction purified from muscle [6] . Thus, identifying the source of the GLUT 1 in studies of its expression in skeletal muscle is necessary, since pure muscle cell membranes cannot be isolated. To circumvent this problem, we determined both the density of GLUT 1in perineurialsheaths of nerves from two different localizations, and the total amount of GLUT 1 in a membrane fraction of skeletal muscle from the same animals. The density of perineurial GLUT 1 was normal in the moderately hyperglycaemic and hyperinsulinaemic, diabetic Zucker rats and unaffected by amelioration of diabetes by metformin treatment. Thus, unlike the situation in muscle cells in culture [25] [26] [27] and in various membrane fractions of muscle [28] , the high-level perineurial expression of GLUT 1 was unaffected by hyperinsulinaemia and hyperglycaemia. The volume fractions of perineurial sheath in the soleus muscles were identical to those determined for Wistar rats in a previous study [6] and unaffected by both the fa/fa gene and the glucose homeostasis. Thereby the total amount ofperineurial GLUT 1 in a given muscle is relatively constant and resistant to changes in glucose homeostasis.
The expression of GLUT 1 was furthermore determined in a crude membrane fraction isolated from homogenates of soleus muscles from the same experimental animals. We found an increased expression of GLUT 1 in the diabetic animals and the increase tended to be reduced following amelioration their of disease. As the perineurial contribution of GLUT 1 was constant, we have demonstrated that GLUT 1 expression in the diabetic fa/fa Zucker rats is preferably increased in the muscle cells. In a recent study, we have demonstrated a decreased expression of GLUT 4 in the same diabetic animals compared to lean littermates [21] , indicating that a reciprocal regulation of GLUT 1 and GLUT 4 in skeletal muscle exists. Indeed, in muscles from all rats (i.e. including those treated with metformin), there was a negative correlation between GLUT 1 and GLUT 4 level. It could be speculated, that the increased GLUT 1 in the diabetic animals might partially compensate for the decreased GLUT 4 expression.
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Whereas there is convincing evidence for a reciprocal regulation of GLUT 1 and GLUT 4 in adipocytes [15, 29] and cultured muscle cells [26, 27, 30] , earlier studies contain less information concerning regulation of transporters in skeletal muscle. Assuming that the present finding of a constant GLUT 1 level in perineurial sheaths can be applied on the various situations described below, the direction of the reported changes should be valid for the muscle cells proper. In agreement with our results, a differential affection of the expression of GLUT 1 and GLUT 4 in skeletal muscle is induced by denervation where GLUT 4 is decreased and GLUT 1 is increased [31] . Fasting and insulinopenic diabetes, however, affects GLUT 1 and GLUT 4 expression in rat skeletal muscle in parallel, both increase with fasting and decrease with diabetes [10, 32] . It is, however, more relevant to compare our results on hyperinsulinaemic diabetic Zucker rats with studies performed under conditions where a certain insulin secretion capacity is preserved. A very recent study was designed to determine the role of circulating blood glucose levels on the number of glucose transporters in isolated membranes from normoinsulinaemic rats in the postabsorptive state. It was found that the effect of hyperglycaemia, in the absence of hypoinsulinaemia, is specific for glucose transporter isoform, with GLUT 1 and GLUT 4 varying in a reciprocal manner with hyperglycaemia [28] . The reciprocal regulation of the expression of the two transporters in obese diabetic Zucker rats proposed here, could also be mediated by plasma glucose. Thus, GLUT 1 correlated directly and GLUT 4 inversely [21] with fasting glucose. It has been suggested that an intracellular glucose metabolite is responsible for the reciprocal regulation of GLUT 4 and GLUT 1 expression [27] . The lack of effect of the increased plasma glucose on GLUT 1 expression in perineurial sheaths in the present fa/fa rats could be due to differences in glucose transport kinetics in perineurial sheaths and muscle cells. Such a difference could result from inherent kinetic differences between GLUT 1 and GLUT 4, and could be amplified by postprandial insulin-induced recruitment of the latter. The amelioration of insulin resistance by metformin treatment of the diabetic rats, indicated by decreased fasting levels of glucose and insulin, could be achieved in part through the increased GLUT 1 expression in skeletal muscle which might increase glucose uptake in this tissue.
In conclusion, the expression of GLUT 1 in perineuriat sheaths is unaffected by the fa/fa gene leading to obesity and insulin-resistant diabetes in the Zucker rat. Furthermore, amelioration of glucose homeostasis did not affect GLUT 1 expression in this tissue. In contrast, GLUT 1 in crude membranes isolated from the soleus muscle was increased in the diabetic rats, likely due to an increased expression in muscle cells, and it is proposed that GLUT 1 and GLUT 4 are differentially regulated in Zucker rats by plasma glucose. The design of future studies of glucose transporter levels in muscle should allow discrimination between GLUT 1 expression in perineurial sheath and in muscle membranes proper.
